Medicine
fromHarvard Gazette
2 days agoWeight-loss drugs reduce risk of heart failure by 40% - Harvard Gazette
Semaglutide or tirzepatide initiation is associated with over 40% lower risk of hospitalization or death in high-risk HFpEF patients with obesity and Type 2 diabetes.